Courthouse News Service | By Maria Dinzeo
Monsanto wrapped its defense with testimony from Dr. Alexandra Levine, an oncologist with the City of Hope cancer center. Levine said decades of spraying Roundup did not contribute to Alva Pilliod’s illness.
Northern California Record | By Rich Peters
The Environmental Protection Agency (EPA) announced in a statement Tuesday that there are “no risks to public health when glyphosate is used in accordance with its current label” and that “glyphosate is not a carcinogen.”
Southern Farm Network
Today, the U.S. Environmental Protection Agency (EPA) is taking an important step in the agency’s review of glyphosate. As part of this action, EPA continues to find that there are no risks to public health when glyphosate is used in accordance with its current label and that glyphosate is not a carcinogen.
Des Moines Register | By Donnelle Eller
The U.S. Environmental Protection Agency on Tuesday reaffirmed its finding that glyphosate, the world’s most popular herbicide, is not a cancer risk to users.
Legal Newsline | By Daniel Fisher Monsanto has appealed a groundbreaking $80 million verdict over its Roundup herbicide, saying the judge committed several serious legal errors and reversed herself on the issue of punitive damages after she was placed on the receiving end of an “extraordinary and coordinated public relations campaign” that included a full-page […]
Law360 | By Emily Field
The jury’s verdict of $289 million, later slashed to $78.5 million, to DeWayne “Lee” Johnson is inconsistent with both the law and sound science, Monsanto said.
Reuters | By Brendan Pierson
In a filing in California’s Court of Appeal, First Appellate District, the company said that there was “no evidence” that glyphosate, a chemical found in the company’s Roundup and Ranger Pro products, could cause cancer.
Agri-Pulse | By Steve Davies
The company, now owned by Bayer, claims in a brief filed in California appellate court that San Francisco Superior Court Judge Suzanne Bolanos was wrong not to allow the jury to consider analyses by U.S. and foreign regulatory agencies concluding glyphosate, the active ingredient in Roundup, does not cause cancer.
The Western Producer
If glyphosate were banned, farmers would either return to tilling to deal with weeds, which would dramatically increase the amount of carbon released into the atmosphere, or use other herbicides that may be worse for the environment.
Bundesinstitut für Risikobewertung
If used properly and for its intended purpose, glyphosate is not carcinogenic. This was the conclusion arrived at by the German Federal Institute for Risk Assessment (BfR) and numerous other national and international authorities.
Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process. The company is now in more control of important aspects of the risk mitigation process and has sketched out two basic scenarios going forward to provide a path to closure of this litigation. The first scenario is based on obtaining a favorable decision by the United States Supreme Court on a cross-cutting issue like federal preemption which would effectively and largely end the U.S. Roundup™ litigation. The second scenario assumes that the Supreme Court either declines to hear the Hardeman case or issues a ruling in favor of plaintiff – in that case the company would activate its own claims administration program.
Read about the five-point plan here.